Evidence map›Paper›PMID 26017790›Full record

ArticleClinics (Sao Paulo, Brazil)2015

Is local resection sufficient for parathyroid carcinoma?

Salim Ilksen Basceken, Volkan Genc, Siyar Ersoz, Yusuf Sevim, Suleyman Utku Celik, Ilknur Kepenekci Bayram

Open access · goldAbstract read
In one paragraph

Article in Clinics (Sao Paulo, Brazil), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 23 citations in OpenAlex.

  1. Critical Insights into Parathyroid Cancer.Journal of cancer science and clinical therapeutics · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Case series of diagnosis and surgery challenges in parathyroid carcinoma.International journal of surgery case reports · 2022
    Article
  6. Local resection versus radical surgery for parathyroid carcinoma: A National Cancer Database analysis.European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2021
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Salim Ilksen BascekenGeneral Surgery, Islahiye State Hospital, Gaziantep, Turkey.
Volkan GencDepartment of General Surgery, Ankara University Medical School, Ankara, Turkey.
Siyar ErsozDepartment of General Surgery, Ankara Numune Training and Research Hospital, Ankara, Turkey.
Yusuf SevimGeneral Surgery, Ankara Penal Institution Campus State Hospital, Ankara, Turkey.
Suleyman Utku CelikDepartment of General Surgery, Ankara University Medical School, Ankara, Turkey.
Ilknur Kepenekci BayramDepartment of General Surgery, Ankara University Medical School, Ankara, Turkey.
Ankara University · TRAnkara Numune Eğitim ve Araştırma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesParathyroid carcinoma is a rare malignant disease of the parathyroid glands that appears in less than 1% of patients with primary hyperparathyroidism. In the literature, the generally recommended treatment is en bloc tumor excision with ipsilateral thyroid lobectomy. Based on our 12 years of experience, we discuss the necessity of performing thyroid lobectomy on parathyroid carcinoma patients.

resultsEleven parathyroid carcinoma cases were included in the study. All operations were performed at the Department of Endocrine Surgery at Ankara University Medical School. Seven of the patients were male (63.6%), and the mean patient age was 48.9 ± 14.0 years. Hyperparathyroidism was the most common indication for surgery (n ϝ 10, 90.9%). Local disease was detected in 5 patients (45.5%), invasive disease was detected in 5 patients (45.5%) and metastatic disease was detected in 1 patient (9.1%). The mean follow-up period was 99.6 ± 42.1 months, and the patients' average disease-free survival was 96.0 ± 49.0 months. During the follow-up period, only 1 patient died of metastatic parathyroid carcinoma.

conclusionParathyroid carcinoma has a slow-growing natural progression, and regional lymph node metastases are uncommon. Although our study comprised few patients, it nevertheless showed that in selected cases, parathyroid carcinoma could be solely treated with parathyroidectomy.

Indexed as

AdultAgedAge FactorsCarcinomaDisease-Free SurvivalFemaleFollow-Up StudiesHumansLymph Node ExcisionMaleMiddle AgedNeoplasm InvasivenessNeoplasm MetastasisParathyroidectomyParathyroid NeoplasmsRetrospective Studies

Identifiers

PMID26017790
PMCPMC4418302
OpenAlexW397251772

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.